Dan Brennan – Cowen & Co.

Cowen & Co.

A Cowen & Co. analyst with 7 tracked ratings across 7 distinct tickers has a 25% success rate on the captured sample, focusing exclusively on the relevant sector.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

3 years ago

2023-02-24 00:00:00+00

Track record

Aggregated

25% success rate

Bullish: 7
Hold: 0
Bearish: 0

Aggregated

Not available

Recent ratings

Ticker	Date	Rating	Price target	Source
NEO	2023-02-24	buy	$20.00	Aggregated
NEONEOGENOMICS INC.	2023-02-24	unknown	$20.00	Aggregated
EXAS	2023-02-22	buy	$76.00	Aggregated
EXASEXACT SCIENCES CORP.	2023-02-22	unknown	$76.00	Aggregated
TXG	2023-02-16	buy	$57.00	Aggregated
TXG10X GENOMICS INC - ORDINARY SHARES - CLASS A	2023-02-16	unknown	$57.00	Aggregated
TMO	2023-02-02	buy	$711.00	Aggregated
TMOTHERMO FISHER SCIENTIFIC INC.	2023-02-02	unknown	$711.00	Aggregated
DHR	2023-01-25	buy	$320.00	Aggregated
DHRDANAHER CORP.	2023-01-25	unknown	$320.00	Aggregated
AVTR	2022-09-14	buy	$28.00	Aggregated
AVTRAVANTOR INC.	2022-09-14	unknown	$28.00	Aggregated
SLGC	2022-08-16	buy	$9.00	Aggregated
SLGC-	2022-08-16	unknown	$9.00	Aggregated

Tickers covered(14)

Ticker	Ratings	Last rating	Sources
NEO	2	2023-02-24	Aggregated
NEONEOGENOMICS INC.	1	2023-02-24	Aggregated
EXAS	2	2023-02-22	Aggregated
EXASEXACT SCIENCES CORP.	1	2023-02-22	Aggregated
TXG	2	2023-02-16	Aggregated
TXG10X GENOMICS INC - ORDINARY SHARES - CLASS A	1	2023-02-16	Aggregated
TMO	2	2023-02-02	Aggregated
TMOTHERMO FISHER SCIENTIFIC INC.	1	2023-02-02	Aggregated
DHR	2	2023-01-25	Aggregated
DHRDANAHER CORP.	1	2023-01-25	Aggregated
AVTR	2	2022-09-14	Aggregated
AVTRAVANTOR INC.	1	2022-09-14	Aggregated
SLGC	2	2022-08-16	Aggregated
SLGC-	1	2022-08-16	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.